Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
7 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 6 EP applications Ludovicus A.G.M. van den Broek has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12160140

Glatiramer acetate human monocytic cell line-based potency assay

IPC classification:
G01N 33/68, G01N 33/50
Applicant:
Synthon BV
Agent:
Ludovicus A.G.M. van den Broek, Synthon BV
Status:
APPLICATION WITHDRAWN
EP12812562

COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES

IPC classification:
C07K 16/24, A61P 19/02, A61P 17/06, A61P 1/00
Agent:
Multiple attorneys, Synthon Biopharmaceuticals B.V.
Agent:
Multiple attorneys, Synthon BV
Status:
GRANT OF PATENT INTENDED
EP12810198

COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES

IPC classification:
C07K 16/24, A61P 19/02, A61P 17/06, A61P 1/00
Agent:
Multiple attorneys, Synthon Biopharmaceuticals B.V.
Agent:
Multiple attorneys, Synthon BV
Status:
GRANT OF PATENT INTENDED
EP12816657

EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED

IPC classification:
C07K 16/24, A61P 19/02, A61P 17/06, A61P 1/00
Agent:
Multiple attorneys, Synthon Biopharmaceuticals B.V.
Agent:
Multiple attorneys, Synthon BV
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12821017

COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES

IPC classification:
C07K 16/24, A61P 19/02, A61P 17/06, A61P 1/00
Agent:
Multiple attorneys, Synthon Biopharmaceuticals B.V.
Agent:
Multiple attorneys, Synthon BV
Status:
GRANT OF PATENT INTENDED
EP16160637

DUOCARMYCIN ADCS SHOWING IMPROVED IN VIVO ANTITUMOR ACTIVITY

IPC classification:
A61K 47/48
Agent:
Ludovicus A.G.M. van den Broek, Synthon BV
Status:
The patent has been granted

Please Sign in to use this feature